Photo taken from: www.fda.gov/about-fda/fda-organization/janet-woodcock
Feb 1, 2024, 22:48
Bishal Gyawali: Very fascinating interview in Endpoints News with Janet Woodcock as she retires from the FDA
Bishal Gyawali, Medical Oncologist and Assistant Professor at Queen’s University, shared on X:
“Very fascinating interview in Endpoints News with Janet Woodcock as she retires from the FDA.
However, I am not aware of any evidence for the claim that survival gains can largely be attributed to therapeutics. We actually discussed this in our eClinicalMedicine – The Lancet Discovery Science paper 2 years ago.”
Source: Bishal Gyawali/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 19:39
Dec 21, 2024, 19:21
Dec 21, 2024, 19:19
Dec 21, 2024, 19:18
Dec 21, 2024, 18:59
Dec 21, 2024, 18:57
Dec 21, 2024, 18:54